文章预览
医学评论英文版原文： Bianco A, D’Agnano V. Real-worldevidence for immune checkpoint inhibitors in extensive-stagesmall cell lung cancer. AME Clin Trials Rev 2024;2:3. 被点评研究： Fujimoto D, Morimoto T, Tamiya M, et al. Outcomes of Chemoimmunotherapy Among Patients With Extensive-Stage Small Cell Lung Cancer According to Potential Clinical Trial Eligibility. JAMA Netw Open 2023;6:e230698. 免疫检查点抑制剂在广泛期小细胞肺癌中应用的真实世界证据 Andrea Bianco 1,2 , Vito D’Agnano 1,2 1 Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, Napoli, Italy; 2 U.O.C. Clinica Pneumologica L. Vanvitelli, Monaldi Hospital, Naples, Italy 翻译：张微微；审校：张正 关键词： 小细胞肺癌（SCLC）；免疫检查点抑制剂（ICIs）；肺癌；化疗；真实世界证据 自从免疫检查点抑制剂（ICIs）用于恶性肿瘤的治疗以来，ICIs已显著改善了患者的预期寿命。
………………………………
